Clay Siegall is the President and Chief Executive Officer of Seattle Genetics, a biotech firm. He is the co-founder of the firm that was established in 1988. On a recent interview with Ideamensch, Clay talks about his idea of creating Seattle Genetics. According to Clay Siegall, he saw the devastating effects of cancer on his father when he was still a teenager. After realizing the resources and tools that are used by cancer treatment specialists and oncologists, he decided to improve them so as to offer improved cancer treatment. Clay says that this is the main reason he started Seattle Genetics.
Clay Siegall also told Ideamensch that he seeks a lot of information from his co-workers so as to make himself to be more productive. An author, he has managed to write more than 70 scientific and medical publications. Clay is also involved with the Washington Roundtable which is anon-profit organization. Clay Siegall is a recipient of the Maryland Alumnus of the Year for Computer, natural Sciences and Math. He acquired this ward due to his contributions to the research of cancer and also pioneering in biotechnology. The success of Seattle Genetics also saw Clay receive the award for the Pacific Northwest Ernst & young Entrepreneur of the Year.
Clay Siegall has worked in therapeutic drug development and cancer research field for more than 20 years and has acquired massive experience and skills. He formerly worked as the Senior Research Investigator at the Bristol-Myers Squibb Pharmaceutical research institute. He also worked as the company’s Principal Scientist. Until April, 2004, Clay Siegall served as the Interim Chairman at the Seattle Genetics. He is also the former Director of the Ultragenyx Pharmaceutical Inc and Alder Biopharmaceuticals Inc. Clay Siegall once worked at the National cancer Institute where he was a Biotechnology Fellow. Because of his efforts in the sector of targeted toxins, Clay Siegall received the Pierce Award.
Clay Siegall attended the George Washington University where he got his Ph.D in Genetics. He also studied at the University of Maryland where he acquired BS in Zoology. He is committed to see a society that is cancer-free.